Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs

Fig. 4

Time to first sequential decrease from baseline. Interactive voice response system (IVRS) Patient Global Assessment of Disease Activity (PtGA) (a) and IVRS Patient Global Assessment of Pain (Pain) (b). A sequential decrease was defined as at least 2 days of consecutive improvement in each measure. BID twice daily

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us